Pineapple, Inc. (PNPL)
USD 0.06
(-10.14%)
USD 0.06
(-10.14%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -1.47 Million USD | -215.74% |
| 2022 | -7.85 Million USD | 51.83% |
| 2021 | -1.09 Million USD | -46.62% |
| 2020 | -1.08 Million USD | 58.85% |
| 2019 | -1.14 Million USD | -64.91% |
| 2018 | -1.22 Million USD | 3.28% |
| 2017 | -813.86 Thousand USD | 71.01% |
| 2016 | -8.3 Million USD | -201.08% |
| 2015 | -1.18 Million USD | -96116.67% |
| 2014 | -1200.00 USD | 59.81% |
| 2013 | -2986.00 USD | -30.62% |
| 2012 | -2286.00 USD | -286.15% |
| 2011 | -592.00 USD | 0.0% |
| 2010 | - USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -466.1 Thousand USD | -2.66% |
| 2023 Q2 | -228.27 Thousand USD | -477.02% |
| 2023 Q3 | -516.51 Thousand USD | -126.27% |
| 2023 FY | - USD | -215.74% |
| 2023 Q4 | -454.03 Thousand USD | 12.1% |
| 2023 Q1 | -39.56 Thousand USD | 54.37% |
| 2022 Q2 | -128.14 Thousand USD | -0.64% |
| 2022 Q4 | -86.69 Thousand USD | 30.7% |
| 2022 FY | - USD | 51.83% |
| 2022 Q1 | -127.31 Thousand USD | 75.61% |
| 2022 Q3 | -125.09 Thousand USD | 2.38% |
| 2021 Q3 | -127.03 Thousand USD | 21.25% |
| 2021 Q2 | -161.3 Thousand USD | -29.35% |
| 2021 Q4 | -521.96 Thousand USD | -310.9% |
| 2021 Q1 | -124.7 Thousand USD | 88.61% |
| 2021 FY | - USD | -46.62% |
| 2020 Q2 | -272.28 Million USD | 1.61% |
| 2020 FY | - USD | 58.85% |
| 2020 Q4 | -1.09 Million USD | -24548.14% |
| 2020 Q3 | 4478.92 USD | 100.0% |
| 2020 Q1 | -276.75 Million USD | 24.06% |
| 2019 Q4 | -364.4 Million USD | 0.0% |
| 2019 FY | - USD | -64.91% |
| 2018 FY | - USD | 3.28% |
| 2018 Q4 | 594.77 Thousand USD | 0.0% |
| 2017 FY | - USD | 71.01% |
| 2016 FY | - USD | -201.08% |
| 2015 Q1 | -541.00 USD | -72.29% |
| 2015 FY | - USD | -96116.67% |
| 2015 Q3 | -594.12 Thousand USD | -544964.22% |
| 2015 Q2 | -109.00 USD | 79.85% |
| 2014 Q2 | 86.00 USD | 110.15% |
| 2014 Q1 | -847.00 USD | 41.14% |
| 2014 FY | - USD | 59.81% |
| 2014 Q4 | -314.00 USD | -151.2% |
| 2014 Q3 | -125.00 USD | -245.35% |
| 2013 Q1 | -847.00 USD | 0.0% |
| 2013 FY | - USD | -30.62% |
| 2013 Q4 | -1439.00 USD | -50.68% |
| 2013 Q3 | -955.00 USD | -474.51% |
| 2013 Q2 | 255.00 USD | 130.11% |
| 2012 FY | - USD | -286.15% |
| 2011 FY | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | -251.11 USD | -587402.688% |
| Allstar Health Brands, Inc. | -241.78 Thousand USD | -510.156% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 89.4 Million USD | 101.65% |
| Café Serendipity Holdings, Inc. | -1.41 Million USD | -4.238% |
| Decision Diagnostics Corp. | - USD | Infinity% |
| Health Advance Inc. | -47.95 Thousand USD | -2976.187% |
| HealthWarehouse.com, Inc. | -1.27 Million USD | -15.68% |
| LIGAND PHARMACEUTICAL INC | 47.23 Million USD | 103.123% |
| MedGen, Inc. | -15.37 USD | -9598325.504% |
| Omni Health, Inc. | 1.28 Million USD | 214.576% |
| Oxford Investments Holdings Inc. | -343.96 Thousand USD | -328.902% |
| ScripsAmerica, Inc. | -3.95 Million USD | 62.693% |